NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Oragenics Inc (NY: OGEN)
0.4357 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:00 PM EST, Jan 27, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 0.4357
Bid (Size) 0.4345 (1)
Ask (Size) 0.6000 (1)
Prev. Close 0.4357
Today's Range 0.4357 - 0.4357
52wk Range 0.3500 - 1.060
Shares Outstanding 6,086,635
Dividend Yield N/A
Performance
YTD
-13.96%
-13.96%
1 Month
-16.68%
-16.68%
3 Month
-3.18%
-3.18%
6 Month
-3.35%
-3.35%
1 Year
-53.15%
-53.15%
Top News
More News
Oragenics Inc. to Present at the LD Micro 12th Annual Main Event on December 10, 2019
Oragenics Inc. to Present at the LD Micro 12th Annual Main Event on December 10, 2019 Read More
from Business Wire News Releases
Oragenics, Inc. Announces Completion of Enrollment of Its Phase 2 Clinical Trial for AG013 in Oral Mucositis
Oragenics, Inc. Announces Completion of Enrollment of Its Phase 2 Clinical Trial for AG013 in Oral Mucositis Read More
from Business Wire News Releases
More News
Read More
Oragenics, Inc. Publishes Peer-Reviewed Study in Journal of Peptide Science Demonstrating First Complete Chemical Synthesis of Bicyclic Ring of a Mutacin 1140 Analog
from Business Wire News Releases
Oragenics, Inc. SVP of Discovery Research, Martin Handfield, Ph.D. to Be Featured Speaker at the International Conference on Microbial Research and Applications
from Business Wire News Releases
Oragenics, Inc. to Present at the BIO Investor Forum
from Business Wire News Releases
Oragenics Presents Interim Data on The AG013 Phase 2 Clinical Trial at the European Society for Medical Oncology Congress 2019
from Business Wire News Releases
Oragenics, Inc. Announces Phase 2 Clinical Trial of AG013 Reaches Enrollment of 158 Patients
from Business Wire News Releases
Oragenics, Inc. to Present Interim Data on AG013 at the European Society of Medical Oncology Congress
from Business Wire News Releases
Oragenics Inc. to Present September 10 at the 21st Annual Rodman and Renshaw Global Investment Conference
from Business Wire News Releases
Investor Expectations to Drive Momentum within H&R Block, Aercap Holdings N.V, Oragenics, and Atomera — Discovering Underlying Factors of Influence
from GlobeNewswire News Releases
Oragenics, Inc. to Present Overview of Lantibiotics Pipeline at the Annual Military Health System Research Symposium
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.